美股異動丨德州儀器盤後升2.38% Q2營收及盈利超預期 多數業務部門恢復訂單增長
德州儀器(TXN.US)美股盤後升2.38%,報203美元。消息面上,德州儀器公佈第二季度業績,營收為38.22億美元,同比下滑15.6%,優於市場預期的36.8億美元;每股盈利1.22美元,高於市場預期的1.16美元。德州儀器首席執行官Haviv Ilan表示,工業部門約一半的市場仍在處理庫存過剩問題,而其他業務部門則一定程度上恢復訂單增長。該公司預計第三季度總營收將在39.4億至42.6億美元之間,分析師預期為41.4億美元;預計每股收益在1.24至1.48美元之間,分析師預期為1.38美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.